Covance Inc.

Public Company, Headquarters Location
210 Carnegie Ctr., Princeton, NJ 08540-6233, United States
(888)268-2623, (609)419-2240, http://www.covance.com

Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Covance, Inc. was started in 1997, when Corning Incorporated spun off its best-of-class drug development companies, which it had acquired throughout the 1980s and 1990s. It holds its headquarters in Princeton, NJ. Covance is a drug development services company that provides a wide range of early-stage and late-stage product development services on a worldwide basis, primarily to the pharmaceutical, biotechnology and medical device industries. The company also provides laboratory testing services to the chemical, agrochemical and food industries. Reportable segments are early development services, which include preclinical services and clinical pharmacology services and late-stage development services, which include central laboratory, clinical development, and commercialization services. In 2008, Covance purchased a minority stake in Caprion Proteomics, a leading provider of proteomics-based services to the pharmaceutical industry. In 2006, and 2005, respectively, the company acquired Radiant Research, Inc., and GFI Clinical Services; and, in 2006, the company acquired Signet Laboratories, Inc. More

Services: Clinical research for pharmaceuticals.